리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2025년 02월
페이지 정보:영문 210 Pages
라이선스 & 가격 (부가세 별도)
한글목차
헬스케어 분야 양자 컴퓨팅 세계 시장은 2030년까지 8억 4,540만 달러에 달할 전망
2024년에 1억 2,850만 달러로 추정되는 헬스케어 분야 양자 컴퓨팅 세계 시장은 2030년에는 8억 4,540만 달러에 달하고, 분석기간인 2024-2030년 CAGR은 36.9%로 성장할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 양자 컴퓨팅 서비스는 CAGR 40.1%를 기록하며 분석기간 종료시에는 4억 5,240만 달러에 달할 것으로 예측됩니다. 양자 컴퓨팅 소프트웨어 부문의 성장률은 분석기간 동안 CAGR 36.2%로 추정됩니다.
미국 시장은 3,620만 달러로 추정, 중국은 CAGR 34.0%로 성장 예측
미국의 헬스케어 분야 양자 컴퓨팅 시장은 2024년에 3,620만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석기간인 2024-2030년 CAGR 34.0%를 기록하며 2030년까지 1억 1,670만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석기간 동안 CAGR은 각각 33.2%와 30.6%로 예측됩니다. 유럽에서는 독일이 CAGR 약 23.2%로 성장할 것으로 예측됩니다.
세계의 헬스케어 분야 양자 컴퓨팅 시장 - 주요 동향과 촉진요인 정리
양자 컴퓨팅은 신약 개발, 임상시험, 환자 데이터 보안 등의 분야에서 획기적인 발전을 가능하게함으로써 헬스케어 분야에 혁명을 일으킬 준비가 되어 있습니다. 양자 역학의 원리를 활용하는 이 기술은 기존 컴퓨터로는 불가능한 속도로 분자 간 상호작용을 시뮬레이션할 수 있어 의약품 개발 시간과 비용을 크게 줄일 수 있으며, Atomwise와 InSilico Medicine과 같은 기업들은 이미 AI를 활용하여 신약 개발 기간을 단축하고 있습니다. 신약 개발의 타임라인을 앞당기고 있으며, 이는 세계 보건 위기에 대한 신속한 대응에 양자 컴퓨팅의 혁신 가능성을 시사하고 있습니다. 의약품에 국한되지 않고, 양자 컴퓨팅은 물리적 피험자 없이도 약물이나 치료 효과를 예측하는 가상 인체 모델을 시뮬레이션함으로써 임상시험에 혁명을 일으키고 의학 연구의 속도와 안전성을 향상시킬 수 있습니다.
양자 컴퓨팅은 유전학 분야에서 유전체 시퀀싱과 분석 과정을 크게 가속화하여 인간 유전체 프로젝트와 같은 프로젝트의 성과를 단기간에 달성할 수 있을 것으로 기대되고 있습니다. 이러한 능력은 유전 질환에 대한 깊은 인사이트를 제공하고, 개인의 유전적 프로필에 맞는 맞춤형 치료를 위한 맞춤형 의료의 발전을 뒷받침할 것으로 기대됩니다. 방대한 유전체 데이터의 원활한 통합은 진단의 정확성과 치료의 개별화를 향상시켜 의료 서비스를 보다 예측 가능하고 효과적으로 만들 수 있습니다. 또한 IBM과 클리블랜드 클리닉과 같은 파트너십에서 볼 수 있듯이, 양자 컴퓨팅을 의료 연구에 지속적으로 통합하는 것은 이론적 응용에서 실용적이고 영향력 있는 의료 활용으로 전환하고 있음을 보여줍니다.
헬스케어 분야에서 양자 컴퓨팅의 성장에는 복잡한 계산과 대규모 데이터세트를 빠르게 처리할 수 있는 잠재력 등 여러 가지 요인이 있습니다. 분자 및 화학적 상호 작용을 미세한 수준에서 시뮬레이션할 수 있는 이 기술은 질병 및 세계 비상사태에 신속하게 대응하는 데 필수적인 의약품 개발을 획기적으로 가속화할 수 있습니다. 또한, 양자 컴퓨팅의 고급 데이터 암호화 기법을 통해 민감한 의료 데이터의 보안을 강화할 수 있을 것으로 기대됩니다. 양자 기술이 성숙해지면 공급망 물류, 환자 데이터 관리, 의료기기 예지보전 등의 프로세스를 간소화하여 업무 효율성을 크게 향상시키고 비용을 절감할 수 있습니다. 헬스케어 분야에서 양자 컴퓨팅의 잠재력을 실현할 수 있는 혁신적인 환경을 조성하기 위해서는 양자 기술 기업, 학계, 의료기관의 협력과 정부 및 민간 부문의 대규모 투자가 필수적입니다.
부문
구성요소(서비스, 소프트웨어, 하드웨어), 기술(초전도 큐비트, 트랩 이온, 양자 어닐링, 기타 기술), 최종사용자(제약 및 바이오제약 기업, 연구소 및 연구기관, 헬스케어 제공자, 헬스케어 지불자)
조사 대상 기업 사례(주목 23개사)
Classiq
D-Wave Systems Inc.
ID Quantique SA
ProteinQure, Inc.
Protiviti Inc.
QC Ware Corp.
Qnami AB
Quantinuum
Rigetti Computing
Zapata Computing
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 성장 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
ksm
영문 목차
영문목차
Global Quantum Computing in Healthcare Market to Reach US$845.4 Million by 2030
The global market for Quantum Computing in Healthcare estimated at US$128.5 Million in the year 2024, is expected to reach US$845.4 Million by 2030, growing at a CAGR of 36.9% over the analysis period 2024-2030. Quantum Computing Services, one of the segments analyzed in the report, is expected to record a 40.1% CAGR and reach US$452.4 Million by the end of the analysis period. Growth in the Quantum Computing Software segment is estimated at 36.2% CAGR over the analysis period.
The U.S. Market is Estimated at US$36.2 Million While China is Forecast to Grow at 34.0% CAGR
The Quantum Computing in Healthcare market in the U.S. is estimated at US$36.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$116.7 Million by the year 2030 trailing a CAGR of 34.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 33.2% and 30.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 23.2% CAGR.
Global Quantum Computing in Healthcare Market - Key Trends and Drivers Summarized
Quantum computing is poised to revolutionize the healthcare sector by enabling groundbreaking advancements in areas like drug discovery, clinical trials, and patient data security. Leveraging the principles of quantum mechanics, this technology allows for the simulation of molecular interactions at speeds unattainable by traditional computers, potentially reducing the time and cost of drug development significantly. Companies like Atomwise and InSilico Medicine are already harnessing AI to accelerate drug discovery timelines, hinting at the transformative potential of quantum computing in responding swiftly to global health crises. Beyond pharmaceuticals, quantum computing could revolutionize clinical trials by simulating virtual human models that predict the effects of drugs and treatments without the need for physical test subjects, thereby enhancing the speed and safety of medical research.
In the field of genetics, quantum computing promises to significantly expedite the process of genome sequencing and analysis, building on the achievements of projects like the Human Genome Project but at a fraction of the time. This capability is expected to unlock profound insights into genetic diseases and support the advancement of personalized medicine, where treatments are tailored to individual genetic profiles. The seamless integration of extensive genomic data could enhance the accuracy of diagnoses and the personalization of treatments, making healthcare more predictive and effective. Additionally, the ongoing integration of quantum computing into healthcare research, as evidenced by partnerships like that between IBM and the Cleveland Clinic, illustrates the transition from theoretical applications to practical, impactful medical uses.
The growth of quantum computing in healthcare is driven by several factors, including its potential to handle complex computations and large datasets rapidly, which is essential for tasks like genomic sequencing and biophysical simulations. The technology's capability to simulate molecular and chemical interactions at a granular level could drastically accelerate drug development, critical for addressing diseases and global health emergencies swiftly. Furthermore, quantum computing's advanced data encryption methods promise enhanced security for sensitive medical data, a growing concern as healthcare data breaches become more prevalent. As quantum technology continues to mature, its integration into healthcare operations could streamline processes such as supply chain logistics, patient data management, and predictive maintenance of medical equipment, significantly enhancing operational efficiency and reducing costs. Collaborations between quantum tech companies, academic institutions, and healthcare organizations, along with substantial governmental and private sector investment, are crucial for nurturing an innovative environment that could bring quantum computing's potential to fruition in the healthcare sector.
SCOPE OF STUDY:
The report analyzes the Quantum Computing in Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.
Select Competitors (Total 23 Featured) -
Classiq
D-Wave Systems Inc.
ID Quantique SA
ProteinQure, Inc.
Protiviti Inc.
QC Ware Corp.
Qnami AB
Quantinuum
Rigetti Computing
Zapata Computing
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Quantum Computing in Healthcare - Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Quantum Computing Speeds Up Drug Discovery
Quantum Cryptography Promises Enhanced Data Security in Healthcare
Accelerated Genome Sequencing Through Quantum Computing Drives Adoption
Quantum Computing in Clinical Trials Throws the Spotlight on Efficiency
Integration of Quantum Computing with AI Expands Clinical Diagnostics Capabilities
Personalized Medicine Through Quantum Computing Attracts R&D Interest
Unraveling the Potential of Quantum Computing in Medical Imaging
Focus on Reducing Healthcare Costs Brings Quantum Computing Into the Spotlight
Quantum Computing in Neurological Research Gives Rise to Quantum Neuroscience
Advances in Quantum Sensors for Medical Monitoring Applications
Regulatory and Ethical Considerations in Quantum Computing Applications
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Quantum Computing in Healthcare Market Analysis of Annual Sales in US$ for Years 2022 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 3: World Historic Review for Quantum Computing in Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 4: World 8-Year Perspective for Quantum Computing in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2022, 2025 & 2030
TABLE 5: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 6: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 7: World 8-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 9: World Historic Review for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 10: World 8-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
TABLE 11: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 12: World Historic Review for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 13: World 8-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 15: World Historic Review for Healthcare Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 16: World 8-Year Perspective for Healthcare Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Healthcare Payers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 18: World Historic Review for Healthcare Payers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 19: World 8-Year Perspective for Healthcare Payers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 21: World Historic Review for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 22: World 8-Year Perspective for Pharma & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Laboratories & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 24: World Historic Review for Laboratories & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 25: World 8-Year Perspective for Laboratories & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Superconducting Qubits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 27: World Historic Review for Superconducting Qubits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 28: World 8-Year Perspective for Superconducting Qubits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
TABLE 29: World Recent Past, Current & Future Analysis for Trapped Ions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 30: World Historic Review for Trapped Ions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 31: World 8-Year Perspective for Trapped Ions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
TABLE 32: World Recent Past, Current & Future Analysis for Quantum Annealing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 33: World Historic Review for Quantum Annealing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 34: World 8-Year Perspective for Quantum Annealing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 36: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 37: World 8-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2022, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Quantum Computing in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 38: USA Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Component - Services, Software and Hardware - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 39: USA Historic Review for Quantum Computing in Healthcare by Component - Services, Software and Hardware Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 40: USA 8-Year Perspective for Quantum Computing in Healthcare by Component - Percentage Breakdown of Value Sales for Services, Software and Hardware for the Years 2022, 2025 & 2030
TABLE 41: USA Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 42: USA Historic Review for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 43: USA 8-Year Perspective for Quantum Computing in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes for the Years 2022, 2025 & 2030
TABLE 44: USA Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 45: USA Historic Review for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 46: USA 8-Year Perspective for Quantum Computing in Healthcare by Technology - Percentage Breakdown of Value Sales for Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies for the Years 2022, 2025 & 2030
CANADA
TABLE 47: Canada Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Component - Services, Software and Hardware - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 48: Canada Historic Review for Quantum Computing in Healthcare by Component - Services, Software and Hardware Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 49: Canada 8-Year Perspective for Quantum Computing in Healthcare by Component - Percentage Breakdown of Value Sales for Services, Software and Hardware for the Years 2022, 2025 & 2030
TABLE 50: Canada Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 52: Canada 8-Year Perspective for Quantum Computing in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes for the Years 2022, 2025 & 2030
TABLE 53: Canada Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 54: Canada Historic Review for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 55: Canada 8-Year Perspective for Quantum Computing in Healthcare by Technology - Percentage Breakdown of Value Sales for Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies for the Years 2022, 2025 & 2030
JAPAN
Quantum Computing in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 56: Japan Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Component - Services, Software and Hardware - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 57: Japan Historic Review for Quantum Computing in Healthcare by Component - Services, Software and Hardware Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 58: Japan 8-Year Perspective for Quantum Computing in Healthcare by Component - Percentage Breakdown of Value Sales for Services, Software and Hardware for the Years 2022, 2025 & 2030
TABLE 59: Japan Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 60: Japan Historic Review for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 61: Japan 8-Year Perspective for Quantum Computing in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes for the Years 2022, 2025 & 2030
TABLE 62: Japan Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 63: Japan Historic Review for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 64: Japan 8-Year Perspective for Quantum Computing in Healthcare by Technology - Percentage Breakdown of Value Sales for Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies for the Years 2022, 2025 & 2030
CHINA
Quantum Computing in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 65: China Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Component - Services, Software and Hardware - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 66: China Historic Review for Quantum Computing in Healthcare by Component - Services, Software and Hardware Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 67: China 8-Year Perspective for Quantum Computing in Healthcare by Component - Percentage Breakdown of Value Sales for Services, Software and Hardware for the Years 2022, 2025 & 2030
TABLE 68: China Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 69: China Historic Review for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 70: China 8-Year Perspective for Quantum Computing in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes for the Years 2022, 2025 & 2030
TABLE 71: China Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 72: China Historic Review for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 73: China 8-Year Perspective for Quantum Computing in Healthcare by Technology - Percentage Breakdown of Value Sales for Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies for the Years 2022, 2025 & 2030
EUROPE
Quantum Computing in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 74: Europe Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Quantum Computing in Healthcare by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 76: Europe 8-Year Perspective for Quantum Computing in Healthcare by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2022, 2025 & 2030
TABLE 77: Europe Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Component - Services, Software and Hardware - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 78: Europe Historic Review for Quantum Computing in Healthcare by Component - Services, Software and Hardware Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 79: Europe 8-Year Perspective for Quantum Computing in Healthcare by Component - Percentage Breakdown of Value Sales for Services, Software and Hardware for the Years 2022, 2025 & 2030
TABLE 80: Europe Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 81: Europe Historic Review for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 82: Europe 8-Year Perspective for Quantum Computing in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes for the Years 2022, 2025 & 2030
TABLE 83: Europe Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 84: Europe Historic Review for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 85: Europe 8-Year Perspective for Quantum Computing in Healthcare by Technology - Percentage Breakdown of Value Sales for Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies for the Years 2022, 2025 & 2030
FRANCE
Quantum Computing in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 86: France Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Component - Services, Software and Hardware - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 87: France Historic Review for Quantum Computing in Healthcare by Component - Services, Software and Hardware Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 88: France 8-Year Perspective for Quantum Computing in Healthcare by Component - Percentage Breakdown of Value Sales for Services, Software and Hardware for the Years 2022, 2025 & 2030
TABLE 89: France Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 90: France Historic Review for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 91: France 8-Year Perspective for Quantum Computing in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes for the Years 2022, 2025 & 2030
TABLE 92: France Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 93: France Historic Review for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 94: France 8-Year Perspective for Quantum Computing in Healthcare by Technology - Percentage Breakdown of Value Sales for Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies for the Years 2022, 2025 & 2030
GERMANY
Quantum Computing in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 95: Germany Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Component - Services, Software and Hardware - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 96: Germany Historic Review for Quantum Computing in Healthcare by Component - Services, Software and Hardware Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 97: Germany 8-Year Perspective for Quantum Computing in Healthcare by Component - Percentage Breakdown of Value Sales for Services, Software and Hardware for the Years 2022, 2025 & 2030
TABLE 98: Germany Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 99: Germany Historic Review for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 100: Germany 8-Year Perspective for Quantum Computing in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes for the Years 2022, 2025 & 2030
TABLE 101: Germany Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 102: Germany Historic Review for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 103: Germany 8-Year Perspective for Quantum Computing in Healthcare by Technology - Percentage Breakdown of Value Sales for Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies for the Years 2022, 2025 & 2030
ITALY
TABLE 104: Italy Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Component - Services, Software and Hardware - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 105: Italy Historic Review for Quantum Computing in Healthcare by Component - Services, Software and Hardware Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 106: Italy 8-Year Perspective for Quantum Computing in Healthcare by Component - Percentage Breakdown of Value Sales for Services, Software and Hardware for the Years 2022, 2025 & 2030
TABLE 107: Italy Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 108: Italy Historic Review for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 109: Italy 8-Year Perspective for Quantum Computing in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes for the Years 2022, 2025 & 2030
TABLE 110: Italy Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 111: Italy Historic Review for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 112: Italy 8-Year Perspective for Quantum Computing in Healthcare by Technology - Percentage Breakdown of Value Sales for Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies for the Years 2022, 2025 & 2030
UNITED KINGDOM
Quantum Computing in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 113: UK Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Component - Services, Software and Hardware - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 114: UK Historic Review for Quantum Computing in Healthcare by Component - Services, Software and Hardware Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 115: UK 8-Year Perspective for Quantum Computing in Healthcare by Component - Percentage Breakdown of Value Sales for Services, Software and Hardware for the Years 2022, 2025 & 2030
TABLE 116: UK Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 117: UK Historic Review for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 118: UK 8-Year Perspective for Quantum Computing in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes for the Years 2022, 2025 & 2030
TABLE 119: UK Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 120: UK Historic Review for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 121: UK 8-Year Perspective for Quantum Computing in Healthcare by Technology - Percentage Breakdown of Value Sales for Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies for the Years 2022, 2025 & 2030
REST OF EUROPE
TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Component - Services, Software and Hardware - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 123: Rest of Europe Historic Review for Quantum Computing in Healthcare by Component - Services, Software and Hardware Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 124: Rest of Europe 8-Year Perspective for Quantum Computing in Healthcare by Component - Percentage Breakdown of Value Sales for Services, Software and Hardware for the Years 2022, 2025 & 2030
TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 126: Rest of Europe Historic Review for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 127: Rest of Europe 8-Year Perspective for Quantum Computing in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes for the Years 2022, 2025 & 2030
TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 129: Rest of Europe Historic Review for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 130: Rest of Europe 8-Year Perspective for Quantum Computing in Healthcare by Technology - Percentage Breakdown of Value Sales for Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies for the Years 2022, 2025 & 2030
ASIA-PACIFIC
Quantum Computing in Healthcare Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Component - Services, Software and Hardware - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 132: Asia-Pacific Historic Review for Quantum Computing in Healthcare by Component - Services, Software and Hardware Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 133: Asia-Pacific 8-Year Perspective for Quantum Computing in Healthcare by Component - Percentage Breakdown of Value Sales for Services, Software and Hardware for the Years 2022, 2025 & 2030
TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 135: Asia-Pacific Historic Review for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 136: Asia-Pacific 8-Year Perspective for Quantum Computing in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes for the Years 2022, 2025 & 2030
TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 138: Asia-Pacific Historic Review for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 139: Asia-Pacific 8-Year Perspective for Quantum Computing in Healthcare by Technology - Percentage Breakdown of Value Sales for Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies for the Years 2022, 2025 & 2030
REST OF WORLD
TABLE 140: Rest of World Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Component - Services, Software and Hardware - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 141: Rest of World Historic Review for Quantum Computing in Healthcare by Component - Services, Software and Hardware Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 142: Rest of World 8-Year Perspective for Quantum Computing in Healthcare by Component - Percentage Breakdown of Value Sales for Services, Software and Hardware for the Years 2022, 2025 & 2030
TABLE 143: Rest of World Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 144: Rest of World Historic Review for Quantum Computing in Healthcare by End-user - Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 145: Rest of World 8-Year Perspective for Quantum Computing in Healthcare by End-user - Percentage Breakdown of Value Sales for Healthcare Providers, Healthcare Payers, Pharma & Biopharma Companies and Laboratories & Research Institutes for the Years 2022, 2025 & 2030
TABLE 146: Rest of World Recent Past, Current & Future Analysis for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 147: Rest of World Historic Review for Quantum Computing in Healthcare by Technology - Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2023 and % CAGR
TABLE 148: Rest of World 8-Year Perspective for Quantum Computing in Healthcare by Technology - Percentage Breakdown of Value Sales for Superconducting Qubits, Trapped Ions, Quantum Annealing and Other Technologies for the Years 2022, 2025 & 2030